Mediaspace 5/2/24 Mediaspace 5/2/24

Luxa Biotechnology Receives $4 Million Grant for Clinical Trial of Dry AMD Treatment

Mediaspace 1/23/24 Mediaspace 1/23/24

Luxa Biotechnology announces paper on 'Identification of Biomarkers for Diversity and Transplantation Efficacy of Retinal Pigment Epithelial Cells' by Dr. Sally Temple.

Mediaspace 1/23/24 Mediaspace 1/23/24

Luxa Biotechnology to Provide Update on Clinical Trial of Retinal Pigmented Epithelium Stem Cell (RPESC) Technology for Treatment of Dry Age-Related Macular Degeneration in Panel Session at ARVO

Mediaspace 1/23/24 Mediaspace 1/23/24

The Report of the Annual Meeting hosted by the National Eye Institute in the United States has been released

Mediaspace 1/23/24 Mediaspace 1/23/24

Sally Temple, Ph.D., named to National Academy of Medicine